(Q41671662)

6 October 2017

1 reference

title

Is there clinical, epidemiological and molecular evidence for two forms of Crohn's disease? (English)

1 reference

6 October 2017

Greenstein RJ

1

1 reference

PubMed ID

9415175

6 October 2017

Greenstein AJ

series ordinal

2

1 reference

6 October 2017

1 October 1995

1 reference

Trends in Molecular Medicine

6 October 2017

1 reference

6 October 2017

1

1 reference

6 October 2017

343-348

1 reference

6 October 2017

7

1 reference

Aetiology of Crohn's disease

6 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2895%2980034-4

7 January 2021

Mycobacterium paratuberculosis DNA in Crohn's disease tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2895%2980034-4

7 January 2021

Crohn's disease: pathogenesis and persistent measles virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2895%2980034-4

7 January 2021

Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2895%2980034-4

7 January 2021

Lipocortin-present perforating and lipocortin-absent nonperforating Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2895%2980034-4

7 January 2021

THE EXTRA-INTESTINAL COMPLICATIONS OF CROHNʼS DISEASE AND ULCERATIVE COLITIS: A STUDY OF 700 PATIENTS

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2895%2980034-4

7 January 2021

Pathogenetic and clinical relevance of cytokines in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2895%2980034-4

7 January 2021

Recurrence of Crohn's disease after primary excisional surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2895%2980034-4

7 January 2021

Defining protective responses to pathogens: cytokine profiles in leprosy lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2895%2980034-4

7 January 2021

Immune regulation: learning from leprosy

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2895%2980034-4

7 January 2021

Cytokine production in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2895%2980034-4

7 January 2021

High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2895%2980034-4

7 January 2021

Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2895%2980034-4

7 January 2021

Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2895%2980034-4

7 January 2021

The lipocortin of colon mucosa in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2895%2980034-4

7 January 2021

Interleukin 1 receptor antagonist. A new member of the interleukin 1 family

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2895%2980034-4

7 January 2021

Interleukin-6 and its receptor: a paradigm for cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2895%2980034-4

7 January 2021

Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2895%2980034-4

7 January 2021

Cytokines increase proliferation of human intestinal smooth muscle cells: possible role in inflammation-induced stricture formation

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2895%2980034-4

7 January 2021

Soluble interleukin-2 receptor, interleukin-6 and interleukin-1 beta in patients with Crohn's disease and ulcerative colitis: preoperative levels and postoperative changes of serum concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2895%2980034-4

7 January 2021

Tumour-necrosis-factor antibody treatment in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2895%2980034-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS1357-4310%2895%2980034-4

1 reference

7 January 2021

Cyclosporin pharmacokinetics after intravenous and oral administration in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2895%2980034-4

7 January 2021

10.1016/S1357-4310(95)80034-4

Identifiers

DOI

1 reference

6 October 2017

1 reference

PubMed ID

9415175